Google DeepMind's AlphaGenome 2 DNA tool opens to researchers
Alphabet's DeepMind research unit built the genome model to help scientists find disease-linked genetic variants more quickly.
By Standard Topic. AI-generated from the reporting listed under Coverage. Published . Updated .
This story is no longer being updated. It reflects reporting up to .
What happened
Google DeepMind has released AlphaGenome 2, an AI model that predicts how genetic variants affect gene activity in specific human cell types rather than across bulk tissue. Genomics Limited also plans to add the model to its Mystra platform.
Why it matters
They also describe it as having potential benefits for drug research.
Timeline
- Nov 11, 2026: DeepMind released AlphaGenome 2, which predicts how DNA changes affect gene activity across cell types.
- Nov 12, 4:39 AM ET: Genomics Limited said it plans to add the model to Mystra, giving drugmakers a way to predict variant effects before choosing what to test.
- Nov 12, 10:55 AM ET: DeepMind made the model's API free for research use, with the figures drawn from its own report.
Coverage
More from Technology & AI
- China puts humanoid robots to work serving food and sorting parcels
- Newsom proposes sweeping AI safety rules for Washington
- Google releases Gemini 4 Neon AI model with million-token context
- Microsoft and Intel widen their cloud chip partnership
- Google DeepMind rolls out Genie 4 to select subscribers
- AI helped AMD shorten chip design work, OpenAI says